FDA Panel Votes to Approve Pfizer’s Vaccine for Children

The benefits of Pfizer’s COVID-19 vaccine for children ages 5 to 11 outweigh its risks, according to an independent panel of vaccine experts that advises the FDA.

Landwebs Landwebs
Oct 29, 2021 - 07:00
0 4
FDA Panel Votes to Approve Pfizer’s Vaccine for Children
doctor preparing child's vaccine

The benefits of Pfizer’s COVID-19 vaccine for children ages 5 to 11 outweigh its risks, according to an independent panel of vaccine experts that advises the FDA.

Read More